01 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE (2)
01 BAUSCH (2)
01 TABLET;ORAL (2)
01 385MG;30MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 770MG;60MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (2)
19
Bausch & Lomb Incorporated, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE, with a corresponding application number 13416 and regulatory information .
proudly manufactured in the
approval since 1982-10-27
Bausch & Lomb Incorporated's NORGESIC TABLET;ORAL, medication with 385MG;30MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE.
18
Bausch & Lomb Incorporated, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE, with a corresponding application number 13416 and regulatory information .
proudly manufactured in the
approval since 1982-10-27
Bausch & Lomb Incorporated's NORGESIC FORTE TABLET;ORAL, medication with 770MG;60MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE.